Newsroom | 12198 results
Sorted by: Latest
-
Eurosets Launches U.S. Commercialization of Trilly and Horizon Following FDA Clearance and Enters Strategic Partnership with Orion Medical
MEDOLLA, Italy & PLYMOUTH, Mich.--(BUSINESS WIRE)--Eurosets is pleased to announce the official start of U.S. commercialization for the Trilly and Horizon oxygenators, following successful FDA 510(k) clearance. This milestone reflects our commitment to supporting clinicians with reliable, high-performance technologies at a time when the U.S. healthcare system continues to face a critical and growing need for oxygenators and life-support solutions. Equipped with an integrated stainless-steel hea...
-
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
SALT LAKE CITY--(BUSINESS WIRE)--The addition of APEXecm reflects Kolosis's continued commitment to developing and commercializing best-in-class solutions for the surgical community....
-
Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 25, 2026
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, has announced that the annual meeting of shareholders of the Company will be held on Wednesday, March 25, 2026 at 2:00pm Eastern Time in a virtual-only format where shareholders may attend and participate in the meeting via live webcast. The meeting will include a presentation from Covalon’s CEO, Brent Ashton, with a Question and Answ...
-
Vergent Bioscience Initiates Phase 3 VISUALIZE 2 Pivotal Study of Abenacianine (VGT-309) for Tumor Visualization During Lung Cancer Surgery
MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company advancing molecularly targeted intraoperative imaging, today announced the initiation of VISUALIZE 2, a Phase 3, multi-center, pivotal study to confirm the safety and efficacy of abenacianine to visualize tumors during lung cancer surgery. Abenacianine is an investigational tumor-activated, intraoperative imaging agent designed to illuminate malignant tissue in patients undergoing surgery for suspected or c...
-
Trice Medical Launches Tenex® 2nd Generation Ultrasonic System, Expanding Minimally Invasive Treatment for Chronic Tendon Pain
MALVERN, Pa.--(BUSINESS WIRE)--Trice Medical today announced nationwide commercial availability of the FDA-cleared Tenex® 2nd Generation System, building on the proven Tenex Health TX® platform that has been used in more than 240,000 procedures. The Tenex 2nd Generation System is an advanced platform designed to expand minimally invasive ultrasonic procedures for the treatment of chronic tendon disease and other musculoskeletal conditions, including calcific deposits, bone spurs, and diabetic f...
-
Renowned Radiosurgery Provider Fully Transitions to ZAP-X® Gyroscopic Radiosurgery® Platform, Marking New Era of Advanced Cranial Radiosurgery
SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that the Miami Neuroscience Center at Larkin Community Hospital has fully transitioned its stereotactic radiosurgery (SRS) program from earlier-generation cobalt-60 (Co-60)–based technology to the modern ZAP-X® Gyroscopic Radiosurgery® platform. Since December 2025, all cranial radiosurgery procedures at the center are now performed using the next-generation ZA...
-
SBC Medical宣布品牌旗艦診所「NEO Skin Clinic Ginza」盛大開幕
加州爾灣--(BUSINESS WIRE)--(美國商業資訊)-- 在多個醫療領域營運廣泛特許經營業務的管理服務機構SBC Medical Group Holdings Incorporated (Nasdaq: SBC)(簡稱「SBC Medical」或「公司」)今日宣布,其專業醫美品牌「NEO Skin Clinic」將於2026年3月28日(週六)在全球知名的醫療觀光中心、競爭激烈的東京銀座區設立旗艦診所。 銀座旗艦診所選址於銀座六(GINZA SIX)附近的黃金地段,將配備專門的VIP包房,服務于頂級客戶和與日俱增的國際病患群體,進一步強化品牌的全球影響力。憑藉其強大的加盟診所網路(截至2025年12月共283家)和豐富的臨床資料,SBC Medical持續推進多品牌策略,以滿足不斷演變的市場需求。 自2025年4月設立Ebisu診所並成功驗證商業模式後,全新的銀座旗艦診所可望透過高附加價值服務模式,進一步推動集團收入來源多元化並提升獲利能力。 醫美產業正快速變革,新型治療器材和配方的不斷湧現提升了消費者的認知和需求。現代病患日益追求尖端醫美科技,對頂級護膚品同樣愈發挑剔。為順...
-
SBC Medical宣布品牌旗舰诊所“NEO Skin Clinic Ginza”盛大开业
加州尔湾--(BUSINESS WIRE)--(美国商业资讯)-- 在多个医疗领域运营广泛特许经营业务的管理服务机构SBC Medical Group Holdings Incorporated (Nasdaq: SBC)(简称“SBC Medical”或“公司”)今日宣布,其专业医美品牌“NEO Skin Clinic”将于2026年3月28日(周六)在全球知名的医疗旅游中心、竞争激烈的东京银座区开设旗舰诊所。 银座旗舰诊所选址于银座六(GINZA SIX)附近的黄金地段,将配备专门的VIP包房,服务于高端客户和日益增长的国际患者群体,进一步强化品牌的全球影响力。凭借其强大的加盟诊所网络(截至2025年12月共283家)和丰富的临床数据,SBC Medical持续推进多品牌战略,以满足不断演变的市场需求。 自2025年4月开设Ebisu诊所并成功验证商业模式后,全新的银座旗舰诊所预计将通过高附加值服务模式,进一步推动集团收入来源多元化并提升盈利能力。 医美行业正快速变革,新型治疗设备和配方的不断涌现提升了消费者的认知和需求。现代患者日益追求前沿医美科技,对高端护肤品同样愈发挑剔。为顺...
-
Riassunto: SBC Medical annuncia l'apertura della "NEO Skin Clinic Ginza", clinica fiore all'occhiello del marchio, clinica fiore all'occhiello del marchio.
IRVINE, Calif.--(BUSINESS WIRE)--SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” o la “Società”), un'organizzazione di servizi di gestione a capo di un'ampia gamma di attività di franchise in vari settori sanitari, oggi ha annunciato che il suo marchio di estetica, “NEO Skin Clinic” aprirà la sua flagship location nel quartiere Ginza di Tokyo, un quartiere hub del turismo sanitario riconosciuto a livello globale e dominato da una forte competitività, sabato 28 marzo 2026. L...
-
SoftAcuity and Atomic Gravity Partner to Advance Physical AI in Mission-Critical Environments — Showcasing Surgical Innovation at NVIDIA GTC
SANTA BARBARA, Calif.--(BUSINESS WIRE)--SoftAcuity, a leader in AI-enabled surgical technologies, today announced new AI capabilities developed in partnership with Atomic Gravity for its Brilliant Assistant platform, advancing the vision of physical AI for mission-critical healthcare environments such as the operating room. The collaboration brings together SoftAcuity’s Brilliant Assistant platform—an advanced surgical display system designed for the digital operating room—with Atomic Gravity’s...